3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
7
Phase 1
7
Phase 2/3
3
Phase 2
3
Phase NA
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
170
Neoplasms
129
Prostatic Neoplasms
92
Lung Neoplasms
82
Colorectal Neoplasms
80
Pancreatic Neoplasms
38
Leiomyoma
37
Carcinoma, Hepatocellular
36
Lymphoma, Follicular
35
Carcinoma, Non-Small-Cell Lung
31
Neoplasm Metastasis
27
Skin Neoplasms
26
Liver Neoplasms
26
Colonic Neoplasms
26
Uterine Cervical Neoplasms
25
Multiple Myeloma
23
Glioblastoma
22
Head and Neck Neoplasms
21
Barrett Esophagus
21
Polycystic Ovary Syndrome
19
Brain Neoplasms
18
Urinary Bladder Neoplasms
17
Polyps
16
Ovarian Neoplasms
15
Esophageal Neoplasms
15
Stomach Neoplasms
14
Squamous Cell Carcinoma of Head and Neck
14
Rectal Neoplasms
14
Carcinoma, Squamous Cell
14
Carcinoma, Basal Cell
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
INDUSTRY
×
Adenoviridae Infections
×
Clear all
NCT02108522
2021-07-20
CHARMS
AlloVir
Phase NA
Completed
82 enrolled
20 charts